Welch & Forbes’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-54,252
Closed -$11.5M 352
2014
Q4
$11.5M Sell
54,252
-555
-1% -$110K 0.34% 83
2014
Q3
$9.77M Buy
54,807
+502
+0.9% +$83.4K 0.3% 88
2014
Q2
$9.19M Sell
54,305
-4,290
-7% -$668K 0.29% 91
2014
Q1
$7.27M Sell
58,595
-190
-0.3% -$23.1K 0.23% 101
2013
Q4
$6.53M Sell
58,785
-426
-0.7% -$40.7K 0.21% 104
2013
Q3
$5.36M Buy
59,211
+291
+0.5% +$26.1K 0.18% 114
2013
Q2
$4.96M Buy
+58,920
New +$6.11M 0.18% 112

Other funds holding AGN

Welch & Forbes's AGN Position: Q1 2015 in Review

Welch & Forbes sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 54,252 shares — an estimated $11.5M sold.

Welch & Forbes first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $11.5M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Welch & Forbes reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Welch & Forbes sold 54,252 Allergan Inc shares in Q1 2015, an estimated $11.5M.
  • Welch & Forbes first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Welch & Forbes's Allergan Inc position peaked at $11.5M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Welch & Forbes's 13F filing for Q1 2015, filed 30 Apr 2015.